94 related articles for article (PubMed ID: 11715667)
1. [In vitro testing for drug resistance and drug sensitivity in clinical oncology].
Kiss I; Zaloudík J; Vyzula R; Tomásek J; Maláska J; Coufal O; Kocáková I
Vnitr Lek; 2001 Sep; 47(9):621-6. PubMed ID: 11715667
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity and chemoresistance testing in ovarian cancer.
Cree IA
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):39-43. PubMed ID: 19125002
[TBL] [Abstract][Full Text] [Related]
3. In vitro drug resistance versus chemosensitivity: two sides of different coins.
Fruehauf JP; Alberts DS
J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
[No Abstract] [Full Text] [Related]
4. An overview of chemosensitivity testing.
Blumenthal RD
Methods Mol Med; 2005; 110():3-18. PubMed ID: 15901922
[TBL] [Abstract][Full Text] [Related]
5. Practical guidelines for diagnostic use of in vitro chemosensitivity tests.
Schinköthe T; Haeger S; Gabri MR
Anticancer Res; 2007; 27(3A):1365-7. PubMed ID: 17593632
[TBL] [Abstract][Full Text] [Related]
6. [Individualization of chemotherapy through in vitro predictive determination of the cytostatic sensitivity of malignant tumors].
Dietel M; Arps H; Bals U; Niendorf A; Henke P; Garbrecht M; Platz D; Weh HJ; Thoma G; Klapdor R
Dtsch Med Wochenschr; 1989 Oct; 114(43):1645-52. PubMed ID: 2806095
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of ornithine decarboxylase as a measure of chemosensitivity testing.
Bachrach U
Methods Mol Med; 2005; 110():197-211. PubMed ID: 15901937
[TBL] [Abstract][Full Text] [Related]
8. [Chemosensitivity test on brain tumors].
Gil-Salú JL; Bosco-López J; Domi Nguez-Villar M; Domínguez-Pascual I; Pérez-Requena J; Palomo MJ; López-Escobar M
Neurocirugia (Astur); 2008 Feb; 19(1):5-11. PubMed ID: 18335150
[TBL] [Abstract][Full Text] [Related]
9. [Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method].
Michalová E; Poprach A; Nemecková I; Nenutil R; Valík D; Zaloudík J; Vyzula R; Vojtesek B
Klin Onkol; 2008; 21(3):93-7. PubMed ID: 19097417
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitivity testing.
Letwin R
Clin J Oncol Nurs; 2001; 5(5):195-200. PubMed ID: 11899765
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer.
d'Amato TA; Landreneau RJ; McKenna RJ; Santos RS; Parker RJ
Ann Thorac Surg; 2006 Feb; 81(2):440-6; discussion 446-7. PubMed ID: 16427828
[TBL] [Abstract][Full Text] [Related]
13. Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.
Sharma S; Neale MH; Di Nicolantonio F; Knight LA; Whitehouse PA; Mercer SJ; Higgins BR; Lamont A; Osborne R; Hindley AC; Kurbacher CM; Cree IA
BMC Cancer; 2003 Jul; 3():19. PubMed ID: 12841853
[TBL] [Abstract][Full Text] [Related]
14. [The prediction of the individual chemosensitivity of human malignant tumors: the biological patterns and clinical results].
Chissov VI; Sergeeva NS; Borisov VI; Skotnikova OI; Sviridova IK
Eksp Klin Farmakol; 1995; 58(1):11-5. PubMed ID: 7787684
[TBL] [Abstract][Full Text] [Related]
15. In vitro testing of chemosensitivity in physiological hypoxia.
Grigoryan R; Keshelava N; Anderson C; Reynolds CP
Methods Mol Med; 2005; 110():87-100. PubMed ID: 15901930
[TBL] [Abstract][Full Text] [Related]
16. Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy.
Weisenthal LM; Su YZ; Duarte TE; Nagourney RA
Prog Clin Biol Res; 1988; 276():75-92. PubMed ID: 3174684
[No Abstract] [Full Text] [Related]
17. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
18. In vitro chemoresistance testing in well-differentiated carcinoid tumors.
Lyons JM; Abergel J; Thomson JL; Anthony CT; Wang YZ; Anthony LB; Boudreaux JP; Strauchen J; Idrees M; Warner RR; Woltering EA
Ann Surg Oncol; 2009 Mar; 16(3):649-55. PubMed ID: 19130141
[TBL] [Abstract][Full Text] [Related]
19. Resistance in malignant tumors: can resistance assays optimize cytostatic chemotherapy?
Lippert TH; Ruoff HJ; Volm M
Pharmacology; 2008; 81(3):196-203. PubMed ID: 18176090
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
